Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway

Neuroscience

• Cell Signaling 100%
• Insulin-Like Growth Factor 1 Receptor 100%
• Dopamine 75%
• Parkinson's Disease 50%
• Dopaminergic 50%
• Tyrosine Hydroxylase 50%
• Substantia nigra 50%
• Striatum 50%
• Apomorphine 50%
• Neuroprotective Agent 50%
• Dopamine Transporter 50%
• Ginsenoside Rg 1 50%
• Neuron 50%
• Protein Bcl 2 25%
• Protein Expression 25%
• Bcl-2 25%
• Receptor Antagonist 25%
• Eicosanoid Receptor 25%
• Oxidopamine 25%
• Gene Expression 25%
• Gene 25%
• Neurotoxicity 25%
• Medial Forebrain Bundle 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Somatomedin C Receptor 100%
• Dopamine 75%
• Dopamine Receptor Stimulating Agent 50%
• Neuroprotective Agent 50%
• Tyrosine 3 Monooxygenase 50%
• Parkinson Disease 50%
• Ginsenoside Rg 1 50%
• Apomorphine 50%
• Dopamine Transporter 50%
• Rat Model 50%
• Injury 50%
• Rat 50%
• Breast Cancer 25%
• Protein Bcl 2 25%
• Neurotoxicity 25%
• Protein 25%
• Receptor 25%
• Oxidopamine 25%
• Phytoestrogen 25%
• Receptor Antagonist 25%
• Absence 25%

Biochemistry, Genetics and Molecular Biology

• Insulin-Like Growth Factor 1 Receptor 100%
• Signal Transduction 100%
• Dopamine 75%
• Circling Behavior 50%
• Tyrosine Hydroxylase 50%
• Dopaminergic 50%
• Rat Model 50%
• Rat 50%
• Apomorphine 50%
• Dopamine Transporter 50%
• Nested Gene 25%
• Protein Expression 25%
• Gene Expression 25%
• Receptor Antagonist 25%
• Bcl-2 25%